<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>49(1)</volume><submitter>Habib DRS</submitter><pubmed_abstract>While artificial intelligence (AI) has demonstrated potential in automating clinical trial matching, most existing solutions rely on high-level structured data or oversimplified criteria. This study introduces a framework to structure and analyze eligibility criteria across three real-world trial protocols, aiming to inform more granular AI-driven trial matching strategies. Trial criteria from three protocols were decomposed into individual variables and evaluated based on data type, scope, and dependency. Complexity was assessed using a novel formula incorporating the number of independent and dependent variables, alongside the Flesch-Kincaid reading grade level. Quantitative analysis explored variation across trials. Protocols contained between 22-160 eligibility variables, with 4-22% sh</pubmed_abstract><journal>Journal of medical systems</journal><pagination>168</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12640310</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Computational Framework for Structuring and Analyzing Clinical Trial Criteria for AI-Guided Fine-grained Matching.</pubmed_title><pmcid>PMC12640310</pmcid><pubmed_authors>Evancha B</pubmed_authors><pubmed_authors>Habib DRS</pubmed_authors><pubmed_authors>Fabbri D</pubmed_authors><pubmed_authors>Mahajan I</pubmed_authors><pubmed_authors>Micheel C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Computational Framework for Structuring and Analyzing Clinical Trial Criteria for AI-Guided Fine-grained Matching.</name><description>While artificial intelligence (AI) has demonstrated potential in automating clinical trial matching, most existing solutions rely on high-level structured data or oversimplified criteria. This study introduces a framework to structure and analyze eligibility criteria across three real-world trial protocols, aiming to inform more granular AI-driven trial matching strategies. Trial criteria from three protocols were decomposed into individual variables and evaluated based on data type, scope, and dependency. Complexity was assessed using a novel formula incorporating the number of independent and dependent variables, alongside the Flesch-Kincaid reading grade level. Quantitative analysis explored variation across trials. Protocols contained between 22-160 eligibility variables, with 4-22% sh</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T18:47:23.073Z</modification><creation>2026-05-20T03:13:50.415Z</creation></dates><accession>S-EPMC12640310</accession><cross_references><pubmed>41273484</pubmed><doi>10.1007/s10916-025-02303-y</doi></cross_references></HashMap>